Monday, 24 February 2020

Pharma News

  • China to blacklist corrupt drugmakers

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2014

    Singapore: China has decided to introduce a healthcare corruption 'blacklist' this 2014 to nab drugmakers and medical device manufacturers found to have paid bribes. As part of its extende...Read more

  • Astellas, Cytokinetics sign $490 mn muscle deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&D and commercialization of skeletal muscle activators. The primary ...Read more

  • Astellas, XenoPort launch Regnite in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

    Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite is approved in Japan for the treatment of moderate-to-severe primary r...Read more

  • KHIDI, UAE armed forces sign healthcare MoA

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Korea Health Industry Development Institute (KHIDI) has signed a memorandum of agreement (MoA) for healthcare cooperation with the UAE Armed Forces on November 21, 2012. The MoA...Read more

  • Karnataka pharma policy: Introduce clusters to enhance sector

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

    Bangalore: The Indian state of Karnataka, which houses the most number of life science firms in the country, unveiled its new pharmaceutical policy. The new policy intends to introduce the ...Read more

  • NZ firm to raise funds for Australia trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 to finance a multi-center phase IIB trial of MIS416 in patients with s...Read more

  • Bangalore is synonymous with Biotech: BIB 2014

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Feb, 2014

    Bangalore: The pioneers from the Biotechnology industry gathered at the Bangalore India Bio 2014, as if with a renewed hope, to strike a chord with those who matter in the industry globally...Read more

  • Taiwan orders removal of 33 drugs off shelves

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: Taiwan's Ministry of Health and Welfare has ordered the removal of 33 drugs from shelves, as they do not conform to their own description. Making the list of drugs public, the m...Read more

  • TSRI, Takeda expand research collaboration

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search for new drug targets for a variety of diseases. The...Read more

  • Chinese police probe GSK staff for 'economic crimes'

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: The Chinese police have been investigating senior staff from the Chinese office of the British drug major GlaxoSmithKline (GSK) for suspected 'economic crimes' according to a st...Read more

  • ShangPharma completes merger

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    ‎Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, has completed the merger with ShangPharma Holdings, Shang...Read more

  • Japanese I'rom acquires 18% in Australian IDT

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading providers of site manag...Read more

  • Indian drug approval mechanism under fire

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2012

    On May 8, when Mr Brajesh Pathak, chairman of India's parliamentary standing committee on health and family welfare, presented its report on the way Central Drugs Standards Control Organiza...Read more

  • Iressa deaths: Japanese High Court rules in favor of AZ

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2012

    Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for the deaths of several individuals due to the side effects of the firm'...Read more

  • Sinopharm bullish on expansion

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

        Sinopharm Group continued to dominate the pharmaceutical industry in China and across the Asia Pacific region in 2011. With China's 12th Five Year Plan for pharmaceutical distribu...Read more

  • Prima recruits patients for cancer vaccine trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized several centers in Ukraine to start enrolling pat...Read more

  • Merck pays Bionomics $172mn for pain molecules

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and Canada, to discover and develop novel small molecule candidates for ...Read more

  • Bayer initiates trial of new rFVIII to treat hemophilia A

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that is designed to evaluate its investigational compound BAY94-9027 for th...Read more